10x Genomics (TXG) Research & Development (2018 - 2026)

10x Genomics has disclosed Research & Development across 9 years of filings, most recently posting $56.8 million for Q2 2026.

• In Q2 2026, Research & Development fell 7.24% year-over-year to $56.8 million; the TTM figure through Jun 2026 stood at $226.8 million (down 12.3% YoY), while the FY2025 annual figure was $238.6 million, down 9.85% from the prior year.
• Research & Development came in at $56.8 million for Q2 2026 at 10x Genomics, roughly flat from $56.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $71.5 million in Q2 2023 to a low of $56.0 million in Q4 2025.
• Average Research & Development over 5 years is $64.1 million, with a median of $64.8 million recorded in 2023.
• Year-over-year, Research & Development surged 52.99% in 2022 and dropped 16.42% in 2025.
• Over 5 years, Research & Development stood at $63.6 million in 2022, then climbed by 2.6% to $65.3 million in 2023, then gained by 2.61% to $67.0 million in 2024, then decreased by 16.42% to $56.0 million in 2025, then grew by 1.47% to $56.8 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $56.8 million in Q2 2026, $56.8 million in Q1 2026, and $56.0 million in Q4 2025.